3 weeks Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings? Zacks

BMY is looking to turn its business around, banking on the strong uptake of new drugs. The recent spate of positive regulatory updates also bodes well for the stock. We recommend investors to wait for better entry levels.